SPECTRUM AND PREVALENCE OF CARDIAC RYANODINE RECEPTOR (RYR2) AND KIR2.1 (KCNJ2) MUTATIONS IN PATIENTS REFERRED FOR FAMILION® CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT) GENETIC TESTING

MLA

Benjamin S. Salisbury, et al. “Spectrum and Prevalence of Cardiac Ryanodine Receptor (Ryr2) and Kir2.1 (Kcnj2) Mutations in Patients Referred for Familion® Catecholaminergic Polymorphic Ventricular Tachycardia (Cpvt) Genetic Testing.” Journal of the American College of Cardiology, no. 13, p. E722. EBSCOhost, https://doi.org/10.1016/S0735-1097(12)60723-2. Accessed 12 Dec. 2024.

APA

Benjamin S. Salisbury, Thomas E. Callis, Janet L. Carr, Lisa Susswein, Michael J. Ackerman, & Guido D. Pollevick. (n.d.). Spectrum and Prevalence of Cardiac Ryanodine Receptor (Ryr2) and Kir2.1 (Kcnj2) Mutations in Patients Referred for Familion® Catecholaminergic Polymorphic Ventricular Tachycardia (Cpvt) Genetic Testing. Journal of the American College of Cardiology, 13, E722. https://doi.org/10.1016/S0735-1097(12)60723-2

Chicago

Benjamin S. Salisbury, Thomas E. Callis, Janet L. Carr, Lisa Susswein, Michael J. Ackerman, and Guido D. Pollevick. 2024. “Spectrum and Prevalence of Cardiac Ryanodine Receptor (Ryr2) and Kir2.1 (Kcnj2) Mutations in Patients Referred for Familion® Catecholaminergic Polymorphic Ventricular Tachycardia (Cpvt) Genetic Testing.” Journal of the American College of Cardiology, no. 13: E722. Accessed December 12. doi:10.1016/S0735-1097(12)60723-2.